Caldwell Trust’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$242 Hold
100
﹤0.01% 782
2025
Q4
$436 Hold
100
﹤0.01% 750
2025
Q3
$420 Hold
100
﹤0.01% 744
2025
Q2
$287 Hold
100
﹤0.01% 743
2025
Q1
$270 Sell
100
-10
-9% -$38 ﹤0.01% 749
2024
Q4
$260 Hold
110
﹤0.01% 711
2024
Q3
$261 Buy
+110
New +$242 ﹤0.01% 701

Other funds holding GNLX

Caldwell Trust's GNLX Position: Q1 2026 in Review

Caldwell Trust held its Genelux (GNLX) position steady in Q1 2026 at 100 shares worth $242. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Caldwell Trust first reported a position in GNLX in Q3 2024 and has held it in 7 quarters since. The position peaked at $436 in Q4 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Caldwell Trust held 100 shares of Genelux worth $242 as of Q1 2026.
  • Caldwell Trust left its Genelux share count unchanged in Q1 2026.
  • Genelux made up ﹤0.01% of Caldwell Trust's portfolio in Q1 2026, its #782 holding.
  • Caldwell Trust first reported a position in Genelux in Q3 2024 and has held it in 7 quarters since.
  • Caldwell Trust's Genelux position peaked at $436 in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.